Ann: Clarifications on suspension and AFR articles, page-48

First 48 Last

Share
Profile

Follow
sdkfgjbwsikfbjg

34 Posts.

112

11/02/23

00:36

Post #: 66190739
Share

Originally posted by 5hareholder: ↑

Poor AVZ.

There are some pretty clear signs here that they are getting very desperate to save face, and I'm afraid to say this has some pretty large red flags:

1. The reference to incidental expenses. Surely immaterial unless you are concerned over cashflow?
2. Why bother with addressing the AFR. If it's unsubstantiated, and the stock is in a halt, it has absolutely no relevance at all. To address it means there must be some substance to it?
3. The timing, late business hours on a Friday. The BoD must be thinking "we need to get something out, anything!". It's totally unnecessary to release news at these hours when the stock is in a halt. Why not wait until Monday, or clarify it within the same day as the AFR article? It reads as indecision and panic.
4. They allude to a leak, but can't identify who or how or why. What confidence do we have in the governance of a project of this scale, if the news of a $1m appointment cant be traced back to the source of the leak?

This is emerging as a really telling story of the risk of investing in DRC, geopolitical game theory, information power and, above all, corporate governance.

This announcement really does not help whatsoever.

Expand

"They allude to a leak, but can't identify who or how or why."

Peter Huljich.

Last edited by sdkfgjbwsikfbjg: 11/02/23

AVZ Price at posting: 78.0¢ Sentiment: Buy Disclosure: Held
4 Upvote

1 Great analysis

Reply

Top Stories

Earnings wrap Monday Week 34: A2 Milk, Bluescope, Suncorp's climate woes & more

SMI

Gold intercept of 8.6 g/t continues the positive storyline for Santana at NZ's RAS deposit

PR1

Fourfold skarn increase points the way to viable garnet project, says Pure

NOX

Noxopharm aims for autoimmune market with first human trial of SOF-SKN

Good habits matters when it comes to finances